Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 USD | -0.38% | -5.42% | -18.47% |
Apr. 05 | North American Morning Briefing : Investors on -2- | DJ |
Apr. 04 | HC Wainwright Downgrades Asensus Surgical to Neutral From Buy, Adjusts PT to $0.35 From $2 | MT |
Financials (USD)
Sales 2024 * | 12.3M | Sales 2025 * | 22.21M | Capitalization | 70.72M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -55M | EV / Sales 2024 * | 5.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
-1.41
x | P/E ratio 2025 * |
-1.79
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.03% |
Latest transcript on Asensus Surgical, Inc.
1 day | -0.38% | ||
1 week | -5.42% | ||
Current month | +13.04% | ||
1 month | -7.14% | ||
3 months | -11.56% | ||
6 months | +2.36% | ||
Current year | -18.47% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Fernando
CEO | Chief Executive Officer | 52 | 15-07-31 |
Director of Finance/CFO | 57 | 20-08-23 | |
Motti Frimer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 04-12-31 | |
Kevin J. Hobert
BRD | Director/Board Member | 59 | 21-07-21 |
William Starling
FOU | Founder | 70 | 98-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 0.26 | -0.38% | 1,391,261 |
24-04-16 | 0.261 | -5.09% | 1,823,986 |
24-04-15 | 0.275 | +1.48% | 1,640,174 |
24-04-12 | 0.271 | -2.55% | 1,349,126 |
24-04-11 | 0.2781 | +1.16% | 1,756,519 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.47% | 70.72M | |
-4.01% | 105B | |
-4.77% | 67.09B | |
+7.87% | 51.61B | |
+16.18% | 47.55B | |
+0.60% | 39.95B | |
+7.17% | 27.62B | |
-1.23% | 25.62B | |
-11.52% | 25.74B | |
+11.40% | 24.93B |
- Stock Market
- Equities
- ASXC Stock